The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | BBG01JLQNZ03 | 14,116,578 | 166,273 | SH | SOLE | 149,997 | 0 | 16,276 | ||
| ADC THERAPEUTICS SA | SHS | H0036K147 | BBG00Q6Q3QX1 | 1,133,144 | 283,286 | SH | SOLE | 283,286 | 0 | 0 | ||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | BBG00L9211Y8 | 5,764,547 | 121,410 | SH | SOLE | 109,809 | 0 | 11,601 | ||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | BBG01WNTXSC8 | 9,688 | 15,500 | SH | Put | SOLE | 15,500 | 0 | 0 | |
| ALKERMES PLC | SHS | G01767105 | BBG000C9F2F9 | 7,249,110 | 241,637 | SH | SOLE | 218,048 | 0 | 23,589 | ||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | BBG00DP10YT5 | 3,761,968 | 276,884 | SH | SOLE | 255,318 | 0 | 21,566 | ||
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | BBG000RR8V85 | 932,462 | 205,388 | SH | SOLE | 185,707 | 0 | 19,681 | ||
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | BBG01RZ6D5M7 | 9,500 | 95,000 | SH | Call | SOLE | 95,000 | 0 | 0 | |
| ARCELLX INC | COMMON STOCK | 03940C100 | BBG00QHJM4S9 | 933,970 | 11,376 | SH | SOLE | 11,376 | 0 | 0 | ||
| ARCTURUS THERAPEUTICS HLDGS | COM | 03969T109 | BBG00NNW8JK1 | 656,219 | 35,606 | SH | SOLE | 32,126 | 0 | 3,480 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG00QN8K4M4 | 7,764,183 | 411,893 | SH | SOLE | 411,893 | 0 | 0 | ||
| ARGENX SE | SPONSORED ADR | 04016X101 | BBG00GHB88X9 | 9,193,685 | 12,465 | SH | SOLE | 12,465 | 0 | 0 | ||
| ARK ETF TR | GENOMIC REV ETF | 00214Q302 | BBG01WVDT824 | 30,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | BBG007R7VNC1 | 3,011,773 | 15,149 | SH | SOLE | 15,149 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | BBG000R62Q06 | 1,692,928 | 66,130 | SH | SOLE | 64,305 | 0 | 1,825 | ||
| ATAI LIFE SCIENCES NV | SHS | N0731H103 | BBG0107FR3K9 | 402,209 | 76,032 | SH | SOLE | 76,032 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | BBG00FQ7LXW1 | 4,969,289 | 114,053 | SH | SOLE | 102,907 | 0 | 11,146 | ||
| BIOHAVEN LTD | COM | G1110E107 | BBG017BXV3Q9 | 15,269,838 | 1,017,311 | SH | SOLE | 905,477 | 0 | 111,834 | ||
| BIOHAVEN LTD | COM | G1110E107 | BBG01WS4WDY8 | 1,188,000 | 480,000 | SH | Call | SOLE | 480,000 | 0 | 0 | |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | 107924102 | BBG01L3GYF02 | 2,160,990 | 186,614 | SH | SOLE | 186,614 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | BBG00P9KDZK6 | 6,618,974 | 127,435 | SH | SOLE | 115,245 | 0 | 12,190 | ||
| CELCUITY INC | COM | 15102K100 | BBG00HKBW045 | 6,753,474 | 136,710 | SH | SOLE | 121,509 | 0 | 15,201 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | BBG01081FC59 | 15,893,086 | 655,385 | SH | SOLE | 589,353 | 0 | 66,032 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | BBG01SDJWCN4 | 905,625 | 172,500 | SH | Call | SOLE | 172,500 | 0 | 0 | |
| CG ONCOLOGY INC | COM | 156944100 | BBG00YHKK4Q3 | 2,538,405 | 63,019 | SH | SOLE | 57,492 | 0 | 5,527 | ||
| CIDARA THERAPEUTICS INC | COM NEW | 171757206 | BBG006R5MFT6 | 14,586,642 | 152,325 | SH | SOLE | 136,836 | 0 | 15,489 | ||
| CLEARPOINT NEURO INC | COM | 18507C103 | BBG000Q39HV3 | 362,825 | 16,651 | SH | SOLE | 16,651 | 0 | 0 | ||
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | BBG00X0VY2N1 | 1,579,303 | 275,620 | SH | SOLE | 275,620 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | BBG009F0TGH8 | 710,755 | 96,439 | SH | SOLE | 96,439 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | BBG01WVJLPN8 | 59,000 | 40,000 | SH | Call | SOLE | 40,000 | 0 | 0 | |
| DENALI THERAPEUTICS INC | COM | 24823R105 | BBG008P7F869 | 25,187,249 | 1,734,659 | SH | SOLE | 1,552,423 | 0 | 182,236 | ||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | BBG00FB2NPZ0 | 1,628,382 | 41,382 | SH | SOLE | 41,382 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | BBG00NSGPJD0 | 6,003,842 | 474,612 | SH | SOLE | 429,193 | 0 | 45,419 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | BBG001V9NSB4 | 900,072 | 75,194 | SH | SOLE | 75,194 | 0 | 0 | ||
| EQUILLIUM INC | COM | 29446K106 | BBG00LSL8C10 | 2,729,777 | 1,908,935 | SH | SOLE | 1,734,418 | 0 | 174,517 | ||
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | BBG011BQC379 | 7,797,433 | 545,275 | SH | SOLE | 475,645 | 0 | 69,630 | ||
| HARROW INC | COM | 415858109 | BBG000QXWY44 | 2,776,083 | 57,619 | SH | SOLE | 57,619 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | BBG00CTZ4D83 | 10,117,358 | 371,825 | SH | SOLE | 330,345 | 0 | 41,480 | ||
| IMMUNOVANT INC | COM | 45258J102 | BBG00P5MC0Q8 | 25,624,030 | 1,589,580 | SH | SOLE | 1,413,520 | 0 | 176,060 | ||
| IMMUNOVANT INC | COM | 45258J102 | BBG01SF3P872 | 50,000 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
| INCYTE CORP | COM | 45337C102 | BBG000BNPSQ9 | 3,710,777 | 43,754 | SH | SOLE | 43,754 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | BBG000BWM5P3 | 6,251,468 | 43,419 | SH | SOLE | 39,173 | 0 | 4,246 | ||
| INVENTIVA SA | ADS | 46124U107 | BBG00VM4C335 | 178,471 | 30,824 | SH | SOLE | 30,824 | 0 | 0 | ||
| INVESCO QQQ TR | UNIT SER 1 | 46090E103 | BBG000BSWKH7 | 2,279,605 | 3,797 | SH | SOLE | 3,797 | 0 | 0 | ||
| INVIVYD INC | COM | 00534A102 | BBG00W4ML039 | 306,469 | 278,608 | SH | SOLE | 278,608 | 0 | 0 | ||
| IONIS PHARMACEUTICALS INC | COM | 462222100 | BBG01X16WD61 | 137,500 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | BBG000G9CGL0 | 5,149,690 | 39,072 | SH | SOLE | 39,072 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | BBG0026ZG5B0 | 691,459 | 56,770 | SH | SOLE | 56,770 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | BBG000QS6NV8 | 3,764,223 | 8,207 | SH | SOLE | 8,207 | 0 | 0 | ||
| MBX BIOSCIENCES INC | COM | 55287L101 | BBG00W7W53M5 | 1,312,500 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| MEIRAGTX HLDGS PLC | COM | G59665102 | BBG00KXH44F2 | 673,691 | 81,858 | SH | SOLE | 81,858 | 0 | 0 | ||
| MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | BBG00F13HYQ7 | 906,356 | 76,875 | SH | SOLE | 76,875 | 0 | 0 | ||
| MINERALYS THERAPEUTICS INC | COM | 603170101 | BBG00ZXN1GN3 | 5,995,607 | 158,112 | SH | SOLE | 142,981 | 0 | 15,131 | ||
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | BBG000BHCYJ1 | 3,027,137 | 53,201 | SH | SOLE | 53,201 | 0 | 0 | ||
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | BBG01BNNTQN4 | 4,282,296 | 150,573 | SH | SOLE | 135,858 | 0 | 14,715 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | BBG001J1BZV0 | 4,202,204 | 359,470 | SH | SOLE | 324,348 | 0 | 35,122 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | BBG00BL5SLH5 | 1,997,532 | 166,461 | SH | SOLE | 166,461 | 0 | 0 | ||
| PEPGEN INC | COM | 713317105 | BBG012232618 | 1,798,053 | 389,189 | SH | SOLE | 351,158 | 0 | 38,031 | ||
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | G70077105 | BBG01N0FG6L0 | 1,590,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | BBG002B63KM7 | 3,185,584 | 47,954 | SH | SOLE | 44,927 | 0 | 3,027 | ||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | BBG001ZLYSH5 | 1,581,947 | 363,666 | SH | SOLE | 363,666 | 0 | 0 | ||
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | BBG00PQFFCV5 | 1,530,774 | 689,538 | SH | SOLE | 630,449 | 0 | 59,089 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | BBG00829F4P8 | 8,657,246 | 185,380 | SH | SOLE | 171,322 | 0 | 14,058 | ||
| REZOLUTE INC | COM NEW | 76200L309 | BBG001XWWHL4 | 8,625,722 | 917,630 | SH | SOLE | 829,871 | 0 | 87,759 | ||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | BBG007DLZ601 | 9,234,930 | 91,444 | SH | SOLE | 82,714 | 0 | 8,730 | ||
| ROIVANT SCIENCES LTD | SHS | G76279101 | BBG007STW2B8 | 63,503,439 | 4,197,187 | SH | SOLE | 3,933,375 | 0 | 263,812 | ||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | BBG00KT2RRM6 | 27,043,837 | 726,204 | SH | SOLE | 646,357 | 0 | 79,847 | ||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | BBG01Q6R0GN4 | 23,920 | 18,400 | SH | Call | SOLE | 18,400 | 0 | 0 | |
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | BBG01X2B0RY2 | 280,000 | 700,000 | SH | Put | SOLE | 700,000 | 0 | 0 | |
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | BBG01X2B0RB7 | 254,852 | 490,100 | SH | Put | SOLE | 490,100 | 0 | 0 | |
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | BBG01X2B0T50 | 190,500 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | BBG01CBVHLW1 | 3,621,380 | 129,335 | SH | SOLE | 129,335 | 0 | 0 | ||
| SURROZEN INC | COM NEW | 86889P208 | BBG00XY94S95 | 9,192,971 | 713,463 | SH | SOLE | 664,313 | 0 | 49,150 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG000R33JY1 | 21,019,064 | 1,366,205 | SH | SOLE | 1,234,315 | 0 | 131,890 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG01SFX0RV4 | 55,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| TANGO THERAPEUTICS INC | COM | 87583X109 | BBG00WFDDRS0 | 2,061,175 | 245,378 | SH | SOLE | 222,548 | 0 | 22,830 | ||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | BBG00TJXFDP1 | 2,745,718 | 839,669 | SH | SOLE | 759,382 | 0 | 80,287 | ||
| TECTONIC THERAPEUTIC INC | COM | 878972108 | BBG00DJ4T7D1 | 2,965,394 | 188,999 | SH | SOLE | 170,981 | 0 | 18,018 | ||
| TERNS PHARMACEUTICALS INC | COM | 880881107 | BBG00KK1SJ08 | 673,024 | 89,617 | SH | SOLE | 89,617 | 0 | 0 | ||
| TREVI THERAPEUTICS INC | COM | 89532M101 | BBG003QGQRB9 | 3,208,997 | 350,710 | SH | SOLE | 317,190 | 0 | 33,520 | ||
| UNIQURE NV | SHS | N90064101 | BBG005SSJYH3 | 30,478,187 | 522,155 | SH | SOLE | 495,313 | 0 | 26,842 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | BBG000BV4XJ1 | 2,625,931 | 6,264 | SH | SOLE | 6,264 | 0 | 0 | ||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | BBG00VC84K29 | 520,832 | 167,470 | SH | SOLE | 167,470 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 6,645,373 | 1,871,936 | SH | SOLE | 1,668,745 | 0 | 203,191 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 1,103,890 | 616,749 | SH | SOLE | 616,749 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | BBG00B642V54 | 15,446,313 | 2,110,152 | SH | SOLE | 1,891,657 | 0 | 218,495 | ||
| WHITEHAWK THERAPEUTICS INC | COM | 00032Q104 | BBG002WN7DT2 | 805,756 | 424,082 | SH | SOLE | 383,457 | 0 | 40,625 | ||
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | BBG001J1CYH8 | 1,899,506 | 555,411 | SH | SOLE | 502,294 | 0 | 53,117 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | BBG0073DM784 | 7,720,644 | 192,295 | SH | SOLE | 172,860 | 0 | 19,435 | ||
| ZENAS BIOPHARMA INC | COM | 98937L105 | BBG01J1MG9D6 | 860,072 | 38,742 | SH | SOLE | 38,742 | 0 | 0 | ||